10-Q · July 28, 2026
Valmont delivered a strong Q2, with revenue up 6.5% to $1.119 billion and EPS of $6.14 versus a $1.53 loss a year earlier; sales and earnings also increased sequentially from Q1. Infrastructure, especially North America…
Earnings analysis · 10-Q
Filed October 27, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q excerpt does not include the financial statements, MD&A, segment disclosures, or quantitative operating results needed to assess revenue, margins, EPS, balance-sheet trends, or cash flow. It reports no…
The supplied 10-Q excerpt does not include the financial statements, MD&A, segment disclosures, or quantitative operating results needed to assess revenue, margins, EPS, balance-sheet trends, or cash flow. It reports no material changes in risk factors during the thirty-nine weeks ended September 26, 2026 and no material changes in market risk. Share repurchases totaled 171,271 shares at an average price of $490.55, leaving approximately $366.5 million of authorization capacity.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
The company repurchased 171,271 shares during the quarter at an average price of $490.55 per share, using $83.99 million of authorization capacity based on the reported share count and average price.
Valmont had approximately $366.5 million of remaining capacity under its $2.1 billion share repurchase authorization as of September 26, 2026.
Management concluded that disclosure controls and procedures were effective as of the end of the period, and reported no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls.
The company states that repurchases are funded through available liquidity and ongoing cash flows and may be discontinued at any time; $366.5 million of authorization remained as of September 26, 2026.
The company reports no material changes in market risk during the thirty-nine weeks ended September 26, 2026; the filing therefore does not provide updated quantitative exposure for market-risk categories.
The provided 10-Q excerpt contains no quantitative revenue or EPS outlook. Prior guidance was disclosed in the October 20, 2026 earnings release, not in the supplied filing text.
Valmont delivered a strong Q2, with revenue up 6.5% to $1.119 billion and EPS of $6.14 versus a $1.53 loss a year earlier; sales and earnings also increased sequentially from Q1. Infrastructure, especially North America…
Valmont reported Q1 FY2026 net sales of $1,029,197,000, up 6.2% year-over-year, with gross margin expanding to 30.8% and operating income rising 21.3% to $155,626,000. Diluted EPS was $5.51, up 27.5% from $4.32 a year…
Valmont reported fiscal 2025 net sales of $4,104.1 million (up $29.1 million vs. 2024) and diluted EPS of $16.79. The company generated strong operating cash flow of $456.5 million and repurchased $198.1 million of…
Valmont reported net sales of $969,314,000 and diluted EPS of $4.32 for the thirteen weeks ended March 29, 2025. Revenue and gross profit declined modestly versus the year-ago quarter, while operating cash flow…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.